rabbit polyclonal h22 cdk4 Search Results


99
NSJ Bioreagents actin antibody
Actin Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/actin antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
actin antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc rabbit polyclonal h22 cdk4
Screening of anti-phosphoT172 <t>CDK4</t> mAbs using immobilized cyclin D3/CDK4 proteic fusions.
Rabbit Polyclonal H22 Cdk4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal h22 cdk4/product/Cell Signaling Technology Inc
Average 92 stars, based on 1 article reviews
rabbit polyclonal h22 cdk4 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology rabbit polyclonal cdk4 antibody
FIG. 3. <t>Cdk4</t> activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928
Rabbit Polyclonal Cdk4 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal cdk4 antibody/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
rabbit polyclonal cdk4 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit polyclonal anti-cdk4 antibodies (ab) (h-22)
FIG. 3. <t>Cdk4</t> activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928
Rabbit Polyclonal Anti Cdk4 Antibodies (Ab) (H 22), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-cdk4 antibodies (ab) (h-22)/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-cdk4 antibodies (ab) (h-22) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc cdk4 d9g3e rabbit mab cell signaling technology 12790s
FIG. 3. <t>Cdk4</t> activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928
Cdk4 D9g3e Rabbit Mab Cell Signaling Technology 12790s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk4 d9g3e rabbit mab cell signaling technology 12790s/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
cdk4 d9g3e rabbit mab cell signaling technology 12790s - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Stressgen Biotechnologies bcl-2 and hsp27 antibody
FIG. 3. <t>Cdk4</t> activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928
Bcl 2 And Hsp27 Antibody, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bcl-2 and hsp27 antibody/product/Stressgen Biotechnologies
Average 90 stars, based on 1 article reviews
bcl-2 and hsp27 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Stressgen Biotechnologies anti-bcl-2
The synergistic effect of paclitaxel and AR activation is attributed to enhanced apoptosis. A, LNCaP cells were seeded on coverslips in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT. The cells were exposed to 10−6 mol/L paclitaxel (PTX) or DMSO control for 24 hours. Cells were fixed and nuclei were stained with Hoechst DNA dye. Left, representative images; right, percentage micronucleated nuclei from at least three experiments done in triplicate. B, LNCaP cells were seeded in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT, and adherent and floating cells were collected after 24 hours of 10−6 mol/L paclitaxel or DMSO control. Isolated protein was immunoblotted with an antibody specific for both full-length and cleaved PARP (106 and 89 kDa, respectively). CDK4 is the loading control. C, LNCaP cells were seeded as described. One hour before paclitaxel exposure, 50 µmol/L Ac-VAD-CHO pan-caspase inhibitor was added to the medium. Following 24 hours of 10−6 mol/L paclitaxel treatment in the presence of Ac-VAD-CHO, cell survival was determined as described previously. D, LNCaP cells were seeded, harvested, and collected as in (B). Isolated protein was immunoblotted with the following: (left) antisera against p53, Ser15 p53, <t>bcl-2,</t> and Bax (numbers correspond to fluorescence intensity of Ser15 p53 relative to no paclitaxel control in the same condition); (middle) antisera against p21CIP1 and Hsp27; (right) antisera against E2F-1.
Anti Bcl 2, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-bcl-2/product/Stressgen Biotechnologies
Average 90 stars, based on 1 article reviews
anti-bcl-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc cdk4 antibodies
Screening of anti-phosphoT172 <t>CDK4</t> mAbs using immobilized cyclin D3/CDK4 proteic fusions.
Cdk4 Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk4 antibodies/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
cdk4 antibodies - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Millipore p53 (ab-6) antibody
Screening of anti-phosphoT172 <t>CDK4</t> mAbs using immobilized cyclin D3/CDK4 proteic fusions.
P53 (Ab 6) Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p53 (ab-6) antibody/product/Millipore
Average 90 stars, based on 1 article reviews
p53 (ab-6) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
NSJ Bioreagents c-myc antibody
Screening of anti-phosphoT172 <t>CDK4</t> mAbs using immobilized cyclin D3/CDK4 proteic fusions.
C Myc Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c-myc antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
c-myc antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Thermo Fisher e2f-1 (ab-3
Screening of anti-phosphoT172 <t>CDK4</t> mAbs using immobilized cyclin D3/CDK4 proteic fusions.
E2f 1 (Ab 3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e2f-1 (ab-3/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
e2f-1 (ab-3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc p21
S130-phosphorylated <t>p21</t> is enriched in phospho-CDK4 immunoprecipitation.
P21, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p21/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
p21 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


Screening of anti-phosphoT172 CDK4 mAbs using immobilized cyclin D3/CDK4 proteic fusions.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Screening of anti-phosphoT172 CDK4 mAbs using immobilized cyclin D3/CDK4 proteic fusions.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques:

Sera evaluation by CDK4 peptide ELISA.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Sera evaluation by CDK4 peptide ELISA.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Peptide ELISA

Evaluation of CDK4 T172-phosphospecificity of immune sera.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Evaluation of CDK4 T172-phosphospecificity of immune sera.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques:

CDK4 T172-phosphospecificity of cloned mAbs.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: CDK4 T172-phosphospecificity of cloned mAbs.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Clone Assay

T172-phosphospecific CDK4 sandwich ELISA.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: T172-phosphospecific CDK4 sandwich ELISA.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Sandwich ELISA

S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Immunoprecipitation

S10-phosphorylated p27 is enriched in phospho-CDK4 immunoprecipitation.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: S10-phosphorylated p27 is enriched in phospho-CDK4 immunoprecipitation.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Immunoprecipitation

FIG. 3. Cdk4 activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928

Journal: Molecular and Cellular Biology

Article Title: c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry

doi: 10.1128/mcb.18.8.4499

Figure Lengend Snippet: FIG. 3. Cdk4 activity following E2 treatment or Zn induction of c-Myc or cyclin D1. The experimental design was as described for Fig. 2A. (A) Cdk4 immunoprecipitates were assayed for kinase activity toward a GST-pRB773-928

Article Snippet: Cdk4 complexes were immunoprecipitated by incubating lysates containing 400 mg of protein with 5 ml of a rabbit polyclonal Cdk4 antibody (H-22; Santa Cruz Biotechnology) for 1 h at 4°C.

Techniques: Activity Assay

The synergistic effect of paclitaxel and AR activation is attributed to enhanced apoptosis. A, LNCaP cells were seeded on coverslips in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT. The cells were exposed to 10−6 mol/L paclitaxel (PTX) or DMSO control for 24 hours. Cells were fixed and nuclei were stained with Hoechst DNA dye. Left, representative images; right, percentage micronucleated nuclei from at least three experiments done in triplicate. B, LNCaP cells were seeded in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT, and adherent and floating cells were collected after 24 hours of 10−6 mol/L paclitaxel or DMSO control. Isolated protein was immunoblotted with an antibody specific for both full-length and cleaved PARP (106 and 89 kDa, respectively). CDK4 is the loading control. C, LNCaP cells were seeded as described. One hour before paclitaxel exposure, 50 µmol/L Ac-VAD-CHO pan-caspase inhibitor was added to the medium. Following 24 hours of 10−6 mol/L paclitaxel treatment in the presence of Ac-VAD-CHO, cell survival was determined as described previously. D, LNCaP cells were seeded, harvested, and collected as in (B). Isolated protein was immunoblotted with the following: (left) antisera against p53, Ser15 p53, bcl-2, and Bax (numbers correspond to fluorescence intensity of Ser15 p53 relative to no paclitaxel control in the same condition); (middle) antisera against p21CIP1 and Hsp27; (right) antisera against E2F-1.

Journal: Cancer research

Article Title: Mitogenic Action of the Androgen Receptor Sensitizes Prostate Cancer Cells to Taxane-Based Cytotoxic Insult

doi: 10.1158/0008-5472.CAN-06-2249

Figure Lengend Snippet: The synergistic effect of paclitaxel and AR activation is attributed to enhanced apoptosis. A, LNCaP cells were seeded on coverslips in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT. The cells were exposed to 10−6 mol/L paclitaxel (PTX) or DMSO control for 24 hours. Cells were fixed and nuclei were stained with Hoechst DNA dye. Left, representative images; right, percentage micronucleated nuclei from at least three experiments done in triplicate. B, LNCaP cells were seeded in CDT + EtOH, FBS, or CDT + 10−10 mol/L DHT, and adherent and floating cells were collected after 24 hours of 10−6 mol/L paclitaxel or DMSO control. Isolated protein was immunoblotted with an antibody specific for both full-length and cleaved PARP (106 and 89 kDa, respectively). CDK4 is the loading control. C, LNCaP cells were seeded as described. One hour before paclitaxel exposure, 50 µmol/L Ac-VAD-CHO pan-caspase inhibitor was added to the medium. Following 24 hours of 10−6 mol/L paclitaxel treatment in the presence of Ac-VAD-CHO, cell survival was determined as described previously. D, LNCaP cells were seeded, harvested, and collected as in (B). Isolated protein was immunoblotted with the following: (left) antisera against p53, Ser15 p53, bcl-2, and Bax (numbers correspond to fluorescence intensity of Ser15 p53 relative to no paclitaxel control in the same condition); (middle) antisera against p21CIP1 and Hsp27; (right) antisera against E2F-1.

Article Snippet: The following antibodies were used: rabbit polyclonal poly(ADP-ribose) polymerase (PARP) and Ser 15 p53 phosphorylated specific (Cell Signaling, Danvers, MA), Bax (N-20) and cyclin-dependent kinase (CDK) 4 (H-22; Santa Cruz Biotechnology, Santa Cruz, CA), E2F-1 (Ab-3; NeoMarkers), p53 (Ab-6; Calbiochem), and bcl-2 and Hsp27 (Stressgen, Ann Arbor, MI).

Techniques: Activation Assay, Staining, Isolation, Fluorescence

Screening of anti-phosphoT172 CDK4 mAbs using immobilized cyclin D3/CDK4 proteic fusions.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Screening of anti-phosphoT172 CDK4 mAbs using immobilized cyclin D3/CDK4 proteic fusions.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques:

Sera evaluation by CDK4 peptide ELISA.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Sera evaluation by CDK4 peptide ELISA.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Peptide ELISA

Evaluation of CDK4 T172-phosphospecificity of immune sera.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: Evaluation of CDK4 T172-phosphospecificity of immune sera.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques:

CDK4 T172-phosphospecificity of cloned mAbs.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: CDK4 T172-phosphospecificity of cloned mAbs.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Clone Assay

T172-phosphospecific CDK4 sandwich ELISA.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: T172-phosphospecific CDK4 sandwich ELISA.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Sandwich ELISA

S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Immunoprecipitation

S10-phosphorylated p27 is enriched in phospho-CDK4 immunoprecipitation.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: S10-phosphorylated p27 is enriched in phospho-CDK4 immunoprecipitation.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Immunoprecipitation

S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Journal: Cell Cycle

Article Title: Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

doi: 10.1080/15384101.2021.1984663

Figure Lengend Snippet: S130-phosphorylated p21 is enriched in phospho-CDK4 immunoprecipitation.

Article Snippet: Equal amounts of whole cell extract protein were separated according to molecular mass and immunodetected using the following antibodies: monoclonal mouse antibodies against cyclin D3 (DCS-22) (Neomarkers/ThermoFisher); cyclin D1 (DCS-6), p16 (DCS-50), CDK4 (DCS-31) (Santa Cruz Biotechnology); p21, p27, CDK4 antibodies (respectively 12D1, D69C12, D9G3E, Cell Signaling Technology); or rabbit polyclonal (H22) CDK4 and anti-phospho-p27 (S10) antibodies (Santa Cruz Biotechnology).

Techniques: Immunoprecipitation